The Biden administration is making billions of dollars available to drugmakers to scale up domestic production of COVID-19 vaccines in the hopes of building capacity to produce an additional 1 billion shots per year to share with the world.
Under the new initiative, the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority is soliciting pharmaceutical companies that have demonstrated the ability to make the more-effective mRNA vaccines to bid for government investment in scaling up their manufacturing abilities. Drugmakers Pfizer and Moderna produce the two US-approved mRNA shots.
The Biden administration believes the boosted capacity of COVID-19 shots will help ease a global shortage of doses, particularly in lower- and middle-income nations, stopping preventable death and limiting the development of potentially new, more dangerous variants of the virus.
The initiative comes as the Biden White House has faced growing pressure at home and abroad over inequity in the global vaccine supply — as the US moves toward approving booster shots for all adults while vulnerable people in poorer nations wait for their first dose of protection.
There are no firm agreements yet with Moderna or Pfizer to take up the US on the investment, but the Biden administration hopes that the enhanced manufacturing capacity, through support for the company’s facilities, equipment, staff or training, will be available by mid-2022 to allow more COVID-19 doses to be shared overseas as well as to prepare for the next public health emergency.
The announcement was previewed Wednesday by an administration official who spoke on the condition of anonymity to discuss the matter before the official release. The New York Times first reported on the new initiative.
US should require COVID vaccine or negative test for domestic air travelers: RepsThree dozen Democratic lawmakers on Friday urged President Joe Biden to require domestic airline passengers to be vaccinated against COVID-19 or show ... Coronavirus
Moderna COVID-19 vaccine patent dispute headed to court: US NIH head saysUS National Institutes of Health scientists played “a major role” in developing Moderna’s COVID-19 vaccine and the agency intends to defend its claim ... Coronavirus
US federal appeals court freezes Biden’s vaccine rule for companiesA US federal appeals court issued a stay on Saturday freezing the Biden administration’s efforts to require workers at US companies with at least 100 ... Coronavirus
US vaccines for children plan fully operational next week, White House saysThe United States is rolling out Pfizer/BioNTech COVID-19 vaccines for children aged 5 to 11 this week, but most of the 15 million shots being shipped ... Coronavirus